Vaccines for this infection have been challenging to produce SAN ANTONIO (Dec. 13, 2022) — The University of Texas Health Science Center at San Antonio has granted an exclusive global license allowing an Ohio biopharmaceutical company to develop university research discoveries into a novel oral vaccine for chlamydia. According to the U.S. Centers for Disease … Continue reading UT Health San Antonio, Ohio company reach license agreement to develop chlamydia vaccine